Renyou
4

Vitiligo

is a relatively common skin condition that affects both men and women, as well as adults and children. It is not contagious. It is not a psychosomatic disease. Vitiligo is associated with the loss of pigment-producing cells in the skin, known as melanocytes. Its mechanisms are multifactorial and complex, involving both genetic and immunological factors. It appears as well-defined, flat, white "achromic" patches, arranged in a roughly symmetrical pattern. Vitiligo does not increase the risk of skin cancer. It is not merely a cosmetic issue: its impact on the quality of life of affected individuals is significant, and it should therefore be managed properly.

Treatment for Vitiligo:

Corticosteroid creams and narrow-band UVB phototherapy are the standard treatments for vitiligo.
Tacrolimus ointment is also used for vitiligo treatment, although it is an off-label (non-approved) use.
Melanocyte transplants are the preferred treatment for stable segmental vitiligo that has lasted for 3 years.
Research continues to advance in understanding and treating vitiligo.
Before
After